New Filings & Updated Terms (9.21.18)

This is the latest look at the IPO Pipeline including the newest filings that have registered with the SEC in the last seven days.

IPO Boutique keeps apprised of the active pipeline. Currently there are 58 active IPOs in the pipeline as of September 21, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why “looks may be perceiving” when it comes to the IPO pipeline in this article.

NEW FILINGS

Company: Osmotica Pharmaceuticals plc
Symbol: OSMT
Description: They are a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Jefferies, Barclays, RBC
Filed: 9-14-18
Listed Cash Raise: $100m

Company: Anaplan, Inc.
Symbol: PLAN
Description: Anaplan is pioneering the category of Connected Planning, which allows organizations to transform their businesses by making better and faster decisions.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Goldman Sachs, Morgan Stanley, Barclays
Co-Manager(s): KeyBanc Capital, Canaccord Genuity, Evercore ISI, JMP Securities, Needham & Co., Piper Jaffray, SunTrust Robinson Humphrey
Filed: 9-14-18
Listed Cash Raise: $100m

Company: Equillium, Inc.
Symbol: EQ
Description: They are a biotechnology company leveraging deep understanding of immunobiology to develop products for severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Jefferies, Leerink, Stifel
Filed: 9-17-18
Listed Cash Raise: $86.25m

Company: SI-BONE, Inc.
Symbol: SIBN
Description: They are a medical device company that has pioneered a proprietary minimally invasive surgical implant system, which they call iFuse, to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Morgan Stanley, BofA Merrill Lynch
Co-Manager(s): Canaccord Genuity, JMP Securities
Filed: 9-20-18
Listed Cash Raise: $97.75m

TERMS ADDED

Company: LAIX Inc.
Symbol: LAIX
Description: They are a leading artificial intelligence (AI) company in China that creates and delivers products and services to popularize English learning.
New York.
Trade Date: 9/27
Shares: 5.75 million ADSs
Price Range: $11.50-$13.50
Underwriter(s): Morgan Stanley, Goldman Sachs (Asia)
Terms Added: 9-14-18

Company: Capital Bancorp, Inc.
Symbol: CBNK
Description: They are a bank holding company and a Maryland corporation, and we operate primarily through their wholly owned subsidiary, Capital Bank, N.A., a commercial-focused community bank based in the Washington, D.C. and Baltimore metropolitan areas.
New York.
Trade Date: 9/26
Shares: 2.23 million
Price Range: $12.50-$14.50
Underwriter(s): Keefe Bruyette & Woods, Stephens Inc.
Co-Manager(s): Sandler O’ Neill , Hovde Group
Terms Added: 9-17-18

Company: Sutro Biopharma, Inc.
Symbol: STRO
Description: They are a clinical stage drug discovery, development and manufacturing company focused on leveraging our proprietary integrated cell-free protein synthesis platform, XpressCF, to create a broad variety of optimally designed, next-generation protein therapeutics for cancer and autoimmune disorders.
Trade Date: 9/27
Shares: 5 million
Price Range: $14.00-$16.00
Underwriters: Cowen, Piper Jaffray
Co-Manager(s): JMP Securities, Wedbush PacGrow
Terms Added: 9-17-18

Company: RA Medical Systems
Symbol: RMED
Description: They are a commercial-stage medical device company leveraging our advanced excimer laser-based platform for use in the treatment of vascular and dermatological diseases.
Trade Date: 9/27
Shares: 3.33 million
Price Range: $14.00-$16.00
Underwriter(s): Piper Jaffray, Cantor
Co-Manager(s): SunTrust Robinson Humphrey, Nomura, Maxim
Terms Added: 9-17-18

Company: Urovant Sciences
Symbol: UROV
Description: They are a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions.
Trade Date: 9/27
Shares: 10 million
Price Range: $14.00-$16.00
Underwriter(s): J.P. Morgan, Jefferies, Cowen
Terms Added: 9-17-18

Company: Gritstone Oncology, Inc.
Symbol: GRTS
Description: They are an immuno-oncology company developing tumor-specific cancer immunotherapies to fight multiple cancer types.
Trade Date: 9/28
Shares: 6.07 million
Price Range: $13.00-$15.00
Underwriter(s): Goldman Sachs, Cowen, Barclays
Co-Manager(s): BTIG
Terms Added: 9-17-18

Company: Entasis Therapeutics Holdings Inc.
Symbol: ETTX
Description: They are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria.
New York.
Trade Date: 9/26
Shares: 4.4 million
Price Range: $16.00-$18.00
Underwriter(s): Credit Suisse, BMO Capital Markets
Co-Manager(s): SunTrust Robinson Humphrey, Wedbush PacGrow
Terms Added: 9-18-18

Company: CooTek (Cayman) Inc.
Symbol: CTK
Description: They are a fast-growing mobile internet company. Sophisticated big data analytics and proprietary AI capability are the backbone of their business.
Trade Date: 9/28
Shares: 4.35 million ADSs
Price Range: $12.00-$14.00
Underwriter(s): Credit Suisse, BofA Merrill Lynch, Citigroup, KeyBanc Capital
Terms Added: 9-19-18

Company: Upwork Inc.
Symbol: UPWK
Description: They operate the largest online global marketplace that enables businesses to find and work with highly-skilled freelancers as measured by gross services volume, or GSV.
Trade Date: 10/3
Shares: 12.27 million
Price Range: $10.00-$12.00
Underwriter(s): Citigroup, Jefferies, RBC, Stifel, JMP Securities
Terms Added: 9-20-18